Entrada Therapeutics, Inc.
NASDAQ:TRDA
19.82 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 67.602 | 45.157 | 291.064 | 39.045 | 16.844 |
| Short Term Investments
| 284.367 | 143.555 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 351.969 | 45.157 | 291.064 | 39.045 | 16.844 |
| Net Receivables
| 7.578 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 10.224 | 21.163 | 7.636 | 0.904 | 0.593 |
| Total Current Assets
| 369.771 | 209.875 | 298.7 | 39.949 | 17.437 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 92.681 | 33.021 | 6.261 | 3.037 | 0.801 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 3.95 | 3.95 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.79 | 5.21 | 0.872 | 0.541 | -0.801 |
| Total Non-Current Assets
| 99.421 | 42.181 | 7.133 | 3.578 | 0.801 |
| Total Assets
| 469.192 | 252.056 | 305.833 | 43.527 | 18.238 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 3.277 | 5.99 | 0.706 | 1.602 | 0.71 |
| Short Term Debt
| 7.909 | 8.406 | 0 | 0 | 0 |
| Tax Payables
| 4.024 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 132.261 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 15.349 | 7.576 | 6.013 | 1.757 | 1.211 |
| Total Current Liabilities
| 158.796 | 21.972 | 6.719 | 3.359 | 1.921 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 60.321 | 17.53 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 7.715 | 0 | 0.396 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| -7.715 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 7.715 | 0 | 0 | 0 | 31.835 |
| Total Non-Current Liabilities
| 68.036 | 17.53 | 0.396 | 81.658 | 31.835 |
| Total Liabilities
| 226.832 | 39.502 | 7.115 | 85.017 | 33.756 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 305.833 | 81.658 | 31.816 |
| Common Stock
| 0.003 | 0.003 | 0.003 | 0.001 | 0.001 |
| Retained Earnings
| -194.97 | -188.285 | -93.669 | -42.511 | -15.988 |
| Accumulated Other Comprehensive Income/Loss
| 0.195 | -2.057 | -305.833 | -81.659 | -31.817 |
| Other Total Stockholders Equity
| 437.132 | 402.893 | 392.384 | 1.021 | 0.47 |
| Total Shareholders Equity
| 242.36 | 212.554 | 298.718 | -41.49 | -15.518 |
| Total Equity
| 242.36 | 212.554 | 298.718 | -41.49 | -15.518 |
| Total Liabilities & Shareholders Equity
| 469.192 | 252.056 | 305.833 | 43.527 | 18.238 |